Antisoma, Betagenon in cancer deal

Betagenon (Stockholm, Sweden) granted Antisoma (LSE:ASM) exclusive, worldwide rights to develop and market its undisclosed preclinical AMP-activated protein kinase (AMPK) activators to treat cancer. B...